Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters

被引:293
作者
Entschladen, F [1 ]
Drell, TL [1 ]
Lang, K [1 ]
Joseph, J [1 ]
Zaenker, KS [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, Signal Transduct Cell Migrat Grp, D-58448 Witten, Germany
关键词
D O I
10.1016/S1470-2045(04)01431-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer starts as a localised disease, which, if detected early, can often be treated successfully by removal of the primary tumour. A pernicious progression is the invasion of tumour cells into surrounding tissues, resulting in development of distant metastases. Because active migration of tumour cells is a prerequisite for tumour-cell invasion and metastasis, a pressing goal in tumour biology has been the elucidation of factors regulating the migratory activity of these cells. The most prominent regulatory factors are ligands to serpentine receptors-eg, chemokines and neurotransmitters. Many types of neurotransmitter receptors are expressed on tumour cells, supporting the theory that psychosocial factors are involved in the progression of cancer. Understanding how such receptors regulate migration and the availability of specific receptor antagonists could open up new avenues for chemoprevention of tumour-cell migration and metastatic development.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 51 条
[31]  
Masur K, 2001, CANCER RES, V61, P2866
[32]   PROOPIOMELANOCORTIN GENE-EXPRESSION IN A DISTINCT POPULATION OF RAT SPLEEN AND LUNG LEUKOCYTES [J].
MECHANICK, JI ;
LEVIN, N ;
ROBERTS, JL ;
AUTELITANO, DJ .
ENDOCRINOLOGY, 1992, 131 (01) :518-525
[33]   Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis [J].
Miyaki, M ;
Iijima, T ;
Konishi, M ;
Sakai, K ;
Ishii, A ;
Yasuno, M ;
Hishima, T ;
Koike, M ;
Shitara, N ;
Iwama, T ;
Utsunomiya, J ;
Kuroki, T ;
Mori, T .
ONCOGENE, 1999, 18 (20) :3098-3103
[34]  
MORIYA T, 1988, ARCH PATHOL LAB MED, V112, P286
[35]   Involvement of chemokine receptors in breast cancer metastasis [J].
Müller, A ;
Homey, B ;
Soto, H ;
Ge, NF ;
Catron, D ;
Buchanan, ME ;
McClanahan, T ;
Murphy, E ;
Yuan, W ;
Wagner, SN ;
Barrera, JL ;
Mohar, A ;
Verástegui, E ;
Zlotnik, A .
NATURE, 2001, 410 (6824) :50-56
[36]   Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR) [J].
Nagakawa, O ;
Murata, J ;
Junicho, A ;
Matsuda, T ;
Fujiuchi, Y ;
Fuse, H ;
Saiki, I .
CANCER LETTERS, 2002, 176 (01) :93-99
[37]  
NAGAO T, 2000, BIOIMAGES, V8, P65
[38]  
Naumov GN, 2002, CANCER RES, V62, P2162
[39]  
Ogasawara M, 1998, ONCOL RES, V10, P361
[40]   A new role for GABA: inhibition of tumor cell migration [J].
Ortega, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (04) :151-154